Search - tctmd.com

Displaying 161 - 180 of 874

Sort: Relevancy | Date

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Presenter: Kevin J. Beatt, Craig R. Smith, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Presenter: J. A. Mustapha, Craig M. Walker, Gary M. Ansel

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron

October 11, 2015

Presentation TCT 2015

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

Presenter: Kevin J. Beatt, Craig R. Smith, Hemal Gada

October 11, 2015

Presentation TCT 2015

The BEST-CLI Study: Rationale and Update

Presenter: J. A. Mustapha, Craig M. Walker, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Perfusion Assessment in Critical Limb Ischemia in 2015

Presenter: J. A. Mustapha, Craig M. Walker, Mehdi H. Shishehbor

October 11, 2015

Presentation TCT 2015

The Team Approach to Critical Limb Ischemia: Who, How, and Why?

Presenter: J. A. Mustapha, Craig M. Walker, Alex Powell

October 11, 2015

Presentation TCT 2015

From COURAGE and BARI 2D to ISCHEMIA: What Answers Can We Expect (and Not Expect) From ISCHEMIA?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Sripal Bangalore

October 11, 2015

Presentation TCT 2015

Introduction: Why Is This Issue Important? Ischemia vs Bleeding

Presenter: Regina Deible, Roxana Mehran

October 11, 2015

Presentation TCT 2015

Nonculprit Lesions in STEMI Patients With Multivessel Disease: Is the Issue Ischemia or Vulnerable Plaque?

Presenter: Thomas Engstroem, Barry D. Rutherford, David Erlinge

October 11, 2015

News Opinion Fellow Talk

Researcher Much? A Brief Review of TCT’s Clinical Trial Design and Interpretation Sessions

October 11, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Daily News

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

Todd Neale

October 08, 2015

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Daily News

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

L.A. McKeown

October 05, 2015

News Industry News

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

September 29, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

News Daily News

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

L.A. McKeown

September 23, 2015

News Daily News

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

L.A. McKeown

September 23, 2015

News Daily News

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

L.A. McKeown

September 23, 2015

Advertisement

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

The BEST-CLI Study: Rationale and Update

Perfusion Assessment in Critical Limb Ischemia in 2015

The Team Approach to Critical Limb Ischemia: Who, How, and Why?

From COURAGE and BARI 2D to ISCHEMIA: What Answers Can We Expect (and Not Expect) From ISCHEMIA?

Introduction: Why Is This Issue Important? Ischemia vs Bleeding

Nonculprit Lesions in STEMI Patients With Multivessel Disease: Is the Issue Ischemia or Vulnerable Plaque?

Researcher Much? A Brief Review of TCT’s Clinical Trial Design and Interpretation Sessions

Novel Devices Present New Treatment Options for STEMI

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content